WebFeb 3, 2024 · The Dopamine in Acute Decompensated Heart Failure (DAD-HF) trial included 60 patients with mean age 76 ± 11 years and mean LVEF 35% ± 12%, could not demonstrate an effect of low-dose dopamine combined with low-dose furosemide compared with high-dose furosemide alone on renal function, diuresis, or CV events . WebDec 1, 2010 · Serum potassium changed from 4.3 ± 0.5 to 3.9 ± 0.4 mEq/L at 24 hours (P = .003) in the HDF group and from 4.4 ± 0.5 to 4.2 ± 0.5 mEq/L at 24 hours (P = .07) in the …
Dapagliflozin in Patients With Heart Failure and Reduced Ejection ...
WebJan 10, 2024 · The VENUS-HF EFS (Early Feasibility Study) trial is a prospective, multicenter, single-arm trial involving 6 centers in the United States and 1 center in the Republic of Georgia to demonstrate the … WebMay 23, 2013 · Meanwhile, the recent Dopamine in Acute Decompensated HF Study (DAD-HF) comparing high-dose furosemide infusion with low-dose furosemide plus low-dose dopamine demonstrated that both treatment strategies had similar effects on urinary output, dyspnea score and outcomes; however, the dopamine group had a lower occurrence of … ipad mini 5 wall mount
Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial - No Study ...
WebMar 1, 2014 · DAD-HF trial, however, did not include a low-dose furosemide (LDF) arm without dopamine infusion. Based on the DAD-HF result, we conducted the DAD-HF II trial to assess the effect of HDF and LDFD, and added an additional LDF arm to assess the impact of these strategies on in-hospital and post-discharge outcomes. 2. Methods2.1. … WebDec 1, 2010 · Serum potassium changed from 4.3 ± 0.5 to 3.9 ± 0.4 mEq/L at 24 hours (P = .003) in the HDF group and from 4.4 ± 0.5 to 4.2 ± 0.5 mEq/L at 24 hours (P = .07) in the LDFD group. Length of stay and 60-day mortality or rehospitalization rates (all-cause, cardiovascular, and worsening HF) were similar in the two groups. WebA small randomized controlled trial (DAD-HF) suggested that the use of low-dose dopamine in patients with acutely decompensated HF was associated with less deterioration in renal function and less hypokalaemia. The MARVEL-1 trial raises further concerns about the safety of myoblast transplantation in ischaemic HF. open office publisher download